Gilead Sciences Inc. (GILD)
NASDAQ · Healthcare
Gilead Sciences Inc. Revenue 2007–2025
Gilead Sciences Inc. annual/quarterly revenue history and growth rate from 2007 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Gilead Sciences Inc. revenue for the quarter ending March 31, 2026 was 7.0 B, a 4.39% increase year-over-year.
- Gilead Sciences Inc. revenue for the twelve months ending March 31, 2026 was 28.5 B, a 0.86% increase year-over-year.
- Gilead Sciences Inc. annual revenue for 2025 was 29.4 B, a 2.40% increase from 2024.
- Gilead Sciences Inc. annual revenue for 2024 was 28.8 B, a 6.04% increase from 2023.
- Gilead Sciences Inc. annual revenue for 2023 was 27.1 B, a 0.60% decrease from 2022.
- Gilead Sciences Inc. annual revenue for 2022 was 27.3 B.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Gilead Sciences Inc. Market Cap — FAQ
Gilead Sciences Inc. (GILD) market cap over the last 19 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see GILD's market cap history?
The chart and table above show Gilead Sciences Inc.'s market cap by year and by quarter, including the growth rate.